Sensory evaluation using mitiglinide / voglibose orally disintegrating tablets (OD tablets) and study of efficacy and safety
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000039068
- Lead Sponsor
- KISSEI PHARMACEUTICAL CO.,LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are judged inappropriate by the research doctor for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensory evaluation questionnaires
- Secondary Outcome Measures
Name Time Method HbA1c Adverse events/Adverse reactions (hypoglycemic symptoms, etc.)